Bioventus (NASDAQ:BVS) Shares Gap Up – Time to Buy?

Shares of Bioventus Inc. (NASDAQ:BVS) gapped up before the market opened on Tuesday . The stock had previously closed at $6.56, but opened at $7.12. Bioventus shares last traded at $7.88, with a volume of 412,672 shares.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Bioventus in a report on Wednesday, October 8th. Wall Street Zen raised shares of Bioventus from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 9th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Bioventus Trading Up 16.2%

The company has a fifty day moving average price of $6.94. The company has a current ratio of 1.48, a quick ratio of 0.96 and a debt-to-equity ratio of 1.48. The stock has a market capitalization of $630.02 million, a price-to-earnings ratio of 13.10 and a beta of 0.80.

Bioventus (NASDAQ:BVS) last posted its earnings results on Tuesday, November 4th. The company reported $0.15 earnings per share for the quarter. Bioventus had a negative net margin of 0.03% and a positive return on equity of 23.04%.

About Bioventus

Bioventus Inc a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body’s natural healing process in the United States and internationally. The company’s portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products.